Topic

UnitedHealthcare (UnitedHealth Group)

A collection of 1322 issues

Renewing Xembify Approval with UnitedHealthcare in Pennsylvania: Timeline, Documents, and Bridge Options

Answer Box: Renewing Xembify Coverage with UnitedHealthcare in Pennsylvania Start your Xembify renewal 30 days before your current authorization expires. UnitedHealthcare typically requires updated IgG trough levels, infection history, and clinical response documentation through OptumRx for pharmacy benefit coverage. Submit via the UnitedHealthcare Provider Portal with complete medical records. If
6 min read

How to Get Opdivo (nivolumab) Covered by UnitedHealthcare in Virginia: Complete Appeals Guide with Forms and Timelines

Answer Box: Getting Opdivo (nivolumab) Covered by UnitedHealthcare in Virginia UnitedHealthcare requires prior authorization for Opdivo (nivolumab) in Virginia, with approval based on FDA-labeled indications, biomarker testing, and documented treatment failures. The fastest path: Submit a complete PA through the UHC Provider Portal with diagnosis, staging, biomarkers (PD-L1, MSI-H/dMMR
6 min read

How to Get Gamifant (Emapalumab-lzsg) Covered by UnitedHealthcare in New York: Prior Authorization, Appeals, and Medical Necessity Requirements

Quick Answer: To get Gamifant (emapalumab-lzsg) covered by UnitedHealthcare in New York, you need prior authorization showing: (1) confirmed primary HLH meeting HLH-2004 criteria, (2) failure/intolerance of conventional therapy (dexamethasone + etoposide), and (3) FDA-label dosing plan. Submit through the UnitedHealthcare Provider Portal with complete diagnostic documentation. If denied, file
5 min read

How to Get Onpattro (patisiran) Covered by UnitedHealthcare in Michigan: Complete Renewal Guide with Appeals Process

Answer Box: Getting Onpattro Covered by UnitedHealthcare in Michigan Onpattro (patisiran) requires prior authorization from UnitedHealthcare in Michigan for hereditary transthyretin-mediated amyloidosis polyneuropathy (hATTR-PN). Submit requests through the UHC Provider Portal with genetic testing, neurologist evaluation, and functional scores (mNIS+7, 6MWT, PND ≤IIIb). UnitedHealthcare must respond within 15 days
6 min read

How to Get Kesimpta (ofatumumab) Covered by UnitedHealthcare in Virginia: Appeals Guide with Forms and Timelines

Answer Box: Getting Kesimpta Covered by UnitedHealthcare in Virginia UnitedHealthcare requires prior authorization for Kesimpta (ofatumumab) with step therapy requirements in Virginia. Most denials stem from missing documentation or inadequate prior DMT failure records. Your fastest path: 1) Gather complete medical records showing relapsing MS diagnosis and prior treatment failures,
6 min read

UnitedHealthcare's Coverage Criteria for Cabometyx (cabozantinib) in Ohio: What Counts as "Medically Necessary"?

Answer Box: Getting Cabometyx Covered by UnitedHealthcare in Ohio UnitedHealthcare requires prior authorization for Cabometyx (cabozantinib) with specific medical necessity criteria by cancer type. Fastest path: Have your oncologist submit PA through the UHC Provider Portal with complete diagnosis, staging, prior therapy documentation, and imaging results. For RCC: Stage IV
5 min read

UnitedHealthcare's Coverage Criteria for Firdapse (amifampridine) in New Jersey: What Counts as "Medically Necessary"?

Answer Box: Getting Firdapse Approved by UnitedHealthcare in New Jersey UnitedHealthcare requires prior authorization for Firdapse (amifampridine) through OptumRx with confirmed LEMS diagnosis by a neurologist, diagnostic testing (EMG and VGCC antibodies), and no seizure history. No step therapy is required. If denied, you have 60 days to appeal internally,
6 min read

How to Get Oxlumo (lumasiran) Covered by UnitedHealthcare in New York: Complete Appeals Guide with Forms and Timelines

Answer Box: Getting Oxlumo Covered by UnitedHealthcare in New York UnitedHealthcare requires prior authorization for Oxlumo (lumasiran) with genetic confirmation of PH1, elevated urinary oxalate levels, and specialist prescriber documentation. Submit through the UHC provider portal with complete clinical records. If denied, you have 30 days for internal appeal, then
6 min read

How to Get Pomalyst (Pomalidomide) Covered by UnitedHealthcare in Florida: Coding, Appeals, and REMS Requirements

Answer Box: Getting Pomalyst Covered by UnitedHealthcare in Florida UnitedHealthcare requires prior authorization for Pomalyst (pomalidomide) with specific documentation: C90.02 (multiple myeloma in relapse) ICD-10 code, proof of prior lenalidomide and proteasome inhibitor failure, and PS-Pomalidomide REMS enrollment. Submit via the UHC Provider Portal with pathology reports, treatment history,
6 min read